Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical Trial.

Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical Trial. JAMA Oncol. 2018 Feb 01; 4(2):230-234.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Dacarbazine
Dexamethasone
Dose-Response Relationship, Drug
Doxorubicin
Drug Resistance, Neoplasm
Female
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Philadelphia Chromosome
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
Salvage Therapy
Survival Analysis
Vincristine
Young Adult

authors with profiles

RICHARD E CHAMPLIN
PARTOW KEBRIAEI
MICHAEL E RYTTING
ZEEV ESTROV
MARINA KONOPLEVA
GUILLERMO GARCIA-MANERO
ELIAS JOSEPH JABBOUR
TAPAN MAHENDRA KADIA
NITIN JAIN
DAVID MARIN
KOICHI TAKAHASHI
HAGOP M KANTARJIAN